| Biofil Chemicals & Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524396 |
NSE Symbol : BIOFILCHEM |
P/E(TTM) : 19.83 |
|
ISIN Demat : INE829A01014 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.76 |
|
Book Value(₹) : 13.09 |
Market Cap(₹Cr) : 56.78 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 13.54 | 6.43 | 8.35 | 14.20 | 2.41 | 8.44 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 13.54 | 6.43 | 8.35 | 14.20 | 2.41 | 8.44 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.06 | 2.83 | 0.24 | 0.02 | 0.02 | 0.03 |
| Total Income | 13.60 | 9.26 | 8.59 | 14.22 | 2.43 | 8.47 |
| Total Expenditure | 13.43 | 6.43 | 8.24 | 13.89 | 2.29 | 8.14 |
| PBIDT | 0.18 | 2.84 | 0.34 | 0.33 | 0.14 | 0.34 |
| Interest | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| PBDT | 0.18 | 2.83 | 0.34 | 0.32 | 0.13 | 0.33 |
| Depreciation | 0.07 | 0.07 | 0.08 | 0.10 | 0.10 | 0.10 |
| Tax | 0.03 | 0.35 | 0.09 | 0.06 | 0.01 | 0.06 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -0.03 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 0.08 | 2.41 | 0.20 | 0.16 | 0.02 | 0.17 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.08 | 2.41 | 0.20 | 0.16 | 0.02 | 0.17 |
| EPS (Unit Curr.) | 0.05 | 1.48 | 0.12 | 0.10 | 0.01 | 0.10 |
| EPS (Adj) (Unit Curr.) | 0.05 | 1.48 | 0.12 | 0.10 | 0.01 | 0.10 |
| Calculated EPS (Unit Curr.) | 0.05 | 1.48 | 0.12 | 0.10 | 0.01 | 0.10 |
| Calculated EPS (Adj) (Unit Curr.) | 0.05 | 1.48 | 0.12 | 0.10 | 0.01 | 0.10 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.21 | 5.93 | 0.49 | 0.40 | 0.06 | 0.42 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.21 | 5.93 | 0.49 | 0.40 | 0.06 | 0.42 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 | 16.27 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 1.33 | 44.17 | 4.07 | 2.32 | 5.81 | 4.03 |
| PBDTM(%) | 1.33 | 44.01 | 4.07 | 2.25 | 5.39 | 3.91 |
| PATM(%) | 0.59 | 37.48 | 2.40 | 1.13 | 0.83 | 2.01 |